• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量微量中和试验的优化

Optimization of a Quantitative Micro-neutralization Assay.

作者信息

Lin Yipu, Gu Yan, McCauley John W

机构信息

Mill Hill Laboratory, The Francis Crick Institute.

Mill Hill Laboratory, The Francis Crick Institute;

出版信息

J Vis Exp. 2016 Dec 14(118):54897. doi: 10.3791/54897.

DOI:10.3791/54897
PMID:28060291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5226418/
Abstract

The micro-neutralization (MN) assay is a standard technique for measuring the infectivity of the influenza virus and the inhibition of virus replication. In this study, we present the protocol of an imaging-based MN assay to quantify the true antigenic relationships between viruses. Unlike typical plaque reduction assays that rely on visible plaques, this assay quantitates the entire infected cell population of each well. The protocol matches the virus type or subtype with the selection of cell lines to achieve maximum infectivity, which enhances sample contrast during imaging and image processing. The introduction of quantitative titration defines the amount of input viruses of neutralization and enables the results from different experiments to be comparable. The imaging setup with a flatbed scanner and free downloadable software makes the approach high throughput, cost effective, user friendly, and easy to deploy in most laboratories. Our study demonstrates that the improved MN assay works well with the current circulating influenza A(H1N1)pdm09, A(H3N2), and B viruses, without being significantly influenced by amino acid substitutions in the neuraminidase (NA) of A(H3N2) viruses. It is particularly useful for the characterization of viruses that either grow to low HA titer and/or undergo an abortive infection resulting in an inability to form plaques in cultured cells.

摘要

微量中和(MN)试验是一种用于测量流感病毒感染性和抑制病毒复制的标准技术。在本研究中,我们展示了一种基于成像的MN试验方案,以量化病毒之间真正的抗原关系。与依赖可见噬斑的典型蚀斑减少试验不同,该试验对每个孔中的整个感染细胞群体进行定量。该方案根据细胞系的选择来匹配病毒类型或亚型,以实现最大感染性,这在成像和图像处理过程中增强了样本对比度。定量滴定的引入定义了中和时输入病毒的量,并使不同实验的结果具有可比性。配备平板扫描仪和免费可下载软件的成像设置使该方法具有高通量、成本效益高、用户友好且易于在大多数实验室中部署的特点。我们的研究表明,改进后的MN试验对当前流行的甲型(H1N1)pdm09、甲型(H3N2)和乙型流感病毒效果良好,不受甲型(H3N2)病毒神经氨酸酶(NA)中氨基酸取代的显著影响。它对于那些在培养细胞中生长至低血凝素滴度和/或经历流产感染而无法形成蚀斑的病毒的特性鉴定特别有用。

相似文献

1
Optimization of a Quantitative Micro-neutralization Assay.定量微量中和试验的优化
J Vis Exp. 2016 Dec 14(118):54897. doi: 10.3791/54897.
2
Optimisation of a micro-neutralisation assay and its application in antigenic characterisation of influenza viruses.微量中和试验的优化及其在流感病毒抗原特性鉴定中的应用
Influenza Other Respir Viruses. 2015 Nov;9(6):331-340. doi: 10.1111/irv.12333.
3
Predominance of influenza A(H3N2) viruses during the 2016/2017 season in Bulgaria.2016/2017年度保加利亚流感季节甲型(H3N2)病毒占主导地位。
J Med Microbiol. 2018 Feb;67(2):228-239. doi: 10.1099/jmm.0.000668. Epub 2018 Jan 3.
4
Antigenic and genetic characterization of influenza viruses circulating in Bulgaria during the 2015/2016 season.2015/2016年流行于保加利亚的流感病毒的抗原性和基因特征
Infect Genet Evol. 2017 Apr;49:241-250. doi: 10.1016/j.meegid.2017.01.027. Epub 2017 Jan 27.
5
Evolution of the hemagglutinin expressed by human influenza A(H1N1)pdm09 and A(H3N2) viruses circulating between 2008-2009 and 2013-2014 in Germany.2008 - 2009年至2013 - 2014年期间在德国传播的甲型H1N1pdm09流感病毒和甲型H3N2流感病毒所表达血凝素的演变情况。
Int J Med Microbiol. 2015 Oct;305(7):762-75. doi: 10.1016/j.ijmm.2015.08.030. Epub 2015 Aug 21.
6
Molecular epidemiology and evolution of A(H1N1)pdm09 and H3N2 virus during winter 2012-2013 in Beijing, China.2012 - 2013年冬季中国北京甲型H1N1流感大流行病毒和H3N2病毒的分子流行病学及进化情况
Infect Genet Evol. 2014 Aug;26:228-40. doi: 10.1016/j.meegid.2014.05.034. Epub 2014 Jun 7.
7
Epidemiological and genetic characterization of pH1N1 and H3N2 influenza viruses circulated in MENA region during 2009-2017.2009-2017 年期间中东和北非地区流行的 pH1N1 和 H3N2 流感病毒的流行病学和遗传特征。
BMC Infect Dis. 2019 Apr 11;19(1):314. doi: 10.1186/s12879-019-3930-6.
8
Antigenic and genetic characterization of influenza viruses isolated in Mozambique during the 2015 season.2015 年莫桑比克流感病毒的抗原性和遗传特征分析。
PLoS One. 2018 Jul 26;13(7):e0201248. doi: 10.1371/journal.pone.0201248. eCollection 2018.
9
Genetic characterisation of influenza A(H1N1)pdm09 viruses circulating in Assam, Northeast India during 2009-2015.2009 - 2015年期间在印度东北部阿萨姆邦流行的甲型H1N1流感大流行病毒的基因特征分析。
Indian J Med Microbiol. 2019 Jan-Mar;37(1):42-49. doi: 10.4103/ijmm.IJMM_18_416.
10
Genetic diversity of influenza A viruses circulating in Bulgaria during the 2018-2019 winter season.保加利亚 2018-2019 年冬季流行的甲型流感病毒的遗传多样性。
J Med Microbiol. 2020 Jul;69(7):986-998. doi: 10.1099/jmm.0.001198.

引用本文的文献

1
Cross-neutralization of Influenza A by SARS-CoV-2 specific neutralizing antibodies and polyclonal plasma: Is pre-exposure to SARS-CoV-2 protective against Influenza A?SARS-CoV-2特异性中和抗体及多克隆血浆对甲型流感的交叉中和作用:预先接触SARS-CoV-2对甲型流感有保护作用吗?
Heliyon. 2024 Nov 22;10(23):e40638. doi: 10.1016/j.heliyon.2024.e40638. eCollection 2024 Dec 15.
2
Sequence-based detection of emerging antigenically novel influenza A viruses.基于序列的新型抗原流感 A 病毒的检测。
Proc Biol Sci. 2024 Aug;291(2028):20240790. doi: 10.1098/rspb.2024.0790. Epub 2024 Aug 14.
3
mRNA vaccines encoding computationally optimized hemagglutinin elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses isolated between 2018-2020.

本文引用的文献

1
Optimisation of a micro-neutralisation assay and its application in antigenic characterisation of influenza viruses.微量中和试验的优化及其在流感病毒抗原特性鉴定中的应用
Influenza Other Respir Viruses. 2015 Nov;9(6):331-340. doi: 10.1111/irv.12333.
2
High throughput virus plaque quantitation using a flatbed scanner.使用平板扫描仪进行高通量病毒噬斑定量分析。
J Virol Methods. 2012 Jan;179(1):81-9. doi: 10.1016/j.jviromet.2011.10.003. Epub 2011 Oct 21.
3
Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?
mRNA 疫苗编码经计算优化的血凝素,可诱导针对 2018-2020 年期间分离的未来抗原漂移的 H1N1 和 H3N2 流感病毒的保护性抗体。
Front Immunol. 2024 Mar 12;15:1334670. doi: 10.3389/fimmu.2024.1334670. eCollection 2024.
4
Immuno-Colorimetric Neutralization Test: A Surrogate for Widely Used Plaque Reduction Neutralization Tests in Public Health Virology.免疫比色中和试验:在公共卫生病毒学中替代广泛使用的噬斑减少中和试验。
Viruses. 2023 Apr 10;15(4):939. doi: 10.3390/v15040939.
5
Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.二价 H1 和 H3 COBRA 重组血凝素疫苗可诱导针对 2009 年至 2019 年 H1N1 和 H3N2 流感病毒的血清保护性抗体。
J Virol. 2022 Apr 13;96(7):e0165221. doi: 10.1128/jvi.01652-21. Epub 2022 Mar 15.
6
Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 Viruses.评估对历史 H3N2 病毒具有预先免疫的雪貂中的下一代 H3 流感疫苗。
Front Immunol. 2021 Aug 12;12:707339. doi: 10.3389/fimmu.2021.707339. eCollection 2021.
7
A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies.用于中和抗体高通量深度分析的综合性流感报告病毒组。
Nat Commun. 2021 Mar 19;12(1):1722. doi: 10.1038/s41467-021-21954-2.
8
Emergence of Zika virus infection in China.中国出现 Zika 病毒感染。
PLoS Negl Trop Dis. 2020 May 19;14(5):e0008300. doi: 10.1371/journal.pntd.0008300. eCollection 2020 May.
9
Improved Specificity and False Discovery Rates for Multiplex Analysis of Changes in Strain-Specific Anti-Influenza IgG.提高多重分析流感特异性 IgG 变化的特异性和假发现率。
Comput Math Methods Med. 2019 Apr 15;2019:3053869. doi: 10.1155/2019/3053869. eCollection 2019.
10
H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation.人感染 H3N2 流感病毒:病毒机制、进化与评估。
Hum Vaccin Immunother. 2018;14(8):1840-1847. doi: 10.1080/21645515.2018.1462639. Epub 2018 May 14.
由于催化位点的天冬氨酸151被取代而产生的甲型H3N2人流感病毒的神经氨酸酶受体结合变体:在病毒附着中起作用?
J Virol. 2010 Jul;84(13):6769-81. doi: 10.1128/JVI.00458-10. Epub 2010 Apr 21.
4
New low-viscosity overlay medium for viral plaque assays.用于病毒蚀斑测定的新型低粘度覆盖培养基。
Virol J. 2006 Aug 31;3:63. doi: 10.1186/1743-422X-3-63.
5
Lack of identity in neutralizing and hemagglutination-inhibiting antibodies against influenza viruses.针对流感病毒的中和抗体及血凝抑制抗体缺乏特异性。
J Exp Med. 1950 Jan 1;91(1):65-86. doi: 10.1084/jem.91.1.65.
6
Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors.MDCK细胞中α-2,6-唾液酸转移酶的过表达增加了流感病毒对神经氨酸酶抑制剂的敏感性。
J Virol. 2003 Aug;77(15):8418-25. doi: 10.1128/jvi.77.15.8418-8425.2003.
7
Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes.近期人类A(H3N2)流感病毒中导致无法凝集鸡红细胞的血凝素残基。
Virology. 2001 Oct 10;289(1):74-85. doi: 10.1006/viro.2001.1121.
8
Influenza virus: a novel method to assess viral and neutralizing antibody titers in vitro.流感病毒:一种在体外评估病毒和中和抗体滴度的新方法。
J Immunol Methods. 1999 May 27;225(1-2):105-11. doi: 10.1016/s0022-1759(99)00034-4.
9
Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.采用多种血清学检测方法联合检测人血清中甲型禽流感病毒(H5N1)抗体。
J Clin Microbiol. 1999 Apr;37(4):937-43. doi: 10.1128/JCM.37.4.937-943.1999.
10
Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection.接种标准(鸡蛋来源)疫苗或自然感染后,人类对B型流感病毒宿主细胞衍生变体的抗体反应。
J Clin Microbiol. 1988 Feb;26(2):333-7. doi: 10.1128/jcm.26.2.333-337.1988.